【结 构 式】 |
【分子编号】37163 【品名】3,4,5-trimethoxyphenol 【CA登记号】 |
【 分 子 式 】C9H12O4 【 分 子 量 】184.19188 【元素组成】C 58.69% H 6.57% O 34.75% |
合成路线1
该中间体在本合成路线中的序号:(V)By reaction of 3,4,5-trimethoxyphenoxyglycidylether (VI) [obtained by reaction of 3,4,5-trimethoxyphenol (V) with epichlorohydrine (II)] with 1-(2-methoxyphenyl)piperazine (I) in refluxing isopropanol.
【1】 Kleemann, A.; DE 2814168 . |
【2】 Engel, J.; Jakovlev, V.; Kleemann, A.; Enciprazine. Drugs Fut 1981, 6, 5, 278. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11882 | 1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine | 35386-24-4 | C11H16N2O | 详情 | 详情 |
(II) | 10146 | Epichlorohydrin; 2-(Chloromethyl)oxirane | 106-89-8 | C3H5ClO | 详情 | 详情 |
(V) | 37163 | 3,4,5-trimethoxyphenol | C9H12O4 | 详情 | 详情 | |
(VI) | 37164 | 2,3-dimethoxy-5-(2-oxiranylmethoxy)phenyl methyl ether; 2-[(3,4,5-trimethoxyphenoxy)methyl]oxirane | C12H16O5 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VI)Isovanillin (I) was protected as the allyl ether (III) by treatment with allyl bromide (II) and K2CO3. Aldehyde reduction of (III) with NaBH4 gave alcohol (IV), which was converted to chloride (V) using SOCl2. Condensation of chloride (V) with the sodium salt of 3,4,5-trimethoxyphenol (VI) produced the corresponding ether (VII). Finally, deprotection of the allyl group of (VII) was achieved by treatment with Wilkinson’s catalyst and DABCO.
【1】 McGown, A.T.; Hadfield, J.A.; Rennison, D.; Woo, M.; Lawrence, N.J.; Antimitotic and cell growth inhibitory properties of combrestastatin A-4-like ethers. Bioorg Med Chem Lett 2001, 11, 1, 51. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18455 | 3-hydroxy-4-methoxybenzaldehyde; Isovanillin | 621-59-0 | C8H8O3 | 详情 | 详情 |
(II) | 11463 | 3-Bromo-1-propene; 3-Bromopropene;allyl bromide | 106-95-6 | C3H5Br | 详情 | 详情 |
(III) | 48348 | 3-Allyloxy-4-methoxybenzaldehyde | C11H12O3 | 详情 | 详情 | |
(IV) | 48349 | [3-(allyloxy)-4-methoxyphenyl]methanol | C11H14O3 | 详情 | 详情 | |
(V) | 48350 | allyl 5-(chloromethyl)-2-methoxyphenyl ether; 2-(allyloxy)-4-(chloromethyl)-1-methoxybenzene | C11H13ClO2 | 详情 | 详情 | |
(VI) | 37163 | 3,4,5-trimethoxyphenol | C9H12O4 | 详情 | 详情 | |
(VII) | 48351 | allyl 2-methoxy-5-[(3,4,5-trimethoxyphenoxy)methyl]phenyl ether; 5-[[3-(allyloxy)-4-methoxybenzyl]oxy]-1,2,3-trimethoxybenzene | C20H24O6 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)The condensation of 3-aminno-4-phenylsulfonyl fluoride (II) with 3,4,5-trimethoxyphenol (I) in the presence of triethylamine furnished the sulfonate ester (III). The amino group of (III) was then acylated with N-Boc-beta-alanine (IV) using EDC and HOBt to yield amide (V). Finally, acid cleavage of the N-Boc protecting group of (V) provided the title aminopropionamide.
【1】 Barr, K.J.; Gwaltney, S.L. II; Imade, H.M.; et al.; Novel sulfonate derivatives: Potent antimitotic agents. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 135. |
【2】 Barr, K.J.; Steiner, B.A.; Qun, L.; Rosenberg, S.; Sham, H.; Gwaltney, S.L. II; Imade, H.M.; Woods, K.W. (Abbott Laboratories Inc.); Cell proliferation inhibitors. WO 0073264 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 37163 | 3,4,5-trimethoxyphenol | C9H12O4 | 详情 | 详情 | |
(II) | 51178 | 4-Methoxymetanilyl fluoride; 3-Amino-4-methoxybenzenesulfonyl fluoride | 498-74-8 | C7H8FNO3S | 详情 | 详情 |
(III) | 51179 | 3,4,5-trimethoxyphenyl 3-amino-4-methoxybenzenesulfonate | C16H19NO7S | 详情 | 详情 | |
(IV) | 26616 | N-(tert-butoxycarbonyl)-beta-alanine | 3303-84-2 | C8H15NO4 | 详情 | 详情 |
(V) | 51180 | 3,4,5-trimethoxyphenyl 3-([3-[(tert-butoxycarbonyl)amino]propanoyl]amino)-4-methoxybenzenesulfonate | C24H32N2O10S | 详情 | 详情 |